Fluorine-18 Labeled Urea-Based Ligands Targeting Prostate-Specific Membrane Antigen (PSMA) with Increased Tumor and Decreased Renal Uptake.
PET
PSMA
biodistribution
fluorine-18
lipophilicity
oxime
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
13 May 2022
13 May 2022
Historique:
received:
05
04
2022
revised:
07
05
2022
accepted:
11
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
High expression of prostate-specific membrane antigen (PSMA) in prostate cancers prompted the development of the PSMA-targeted PET-imaging agent [
Identifiants
pubmed: 35631423
pii: ph15050597
doi: 10.3390/ph15050597
pmc: PMC9144807
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NIH HHS
ID : HHSN261200800001E
Pays : United States
Références
Clin Cancer Res. 2008 May 15;14(10):3036-43
pubmed: 18483369
J Nucl Med. 2016 Oct;57(Suppl 3):43S-48S
pubmed: 27694171
Neoplasia. 2020 Nov;22(11):566-575
pubmed: 32980775
J Nucl Med. 2018 Jul;59(7):1076-1080
pubmed: 29269569
Cancer Imaging. 2019 May 15;19(1):23
pubmed: 31092293
Mod Pathol. 2015 Jan;28(1):138-45
pubmed: 24925052
J Nucl Med. 2021 May 10;62(5):596-604
pubmed: 33712536
Mol Pharm. 2009 May-Jun;6(3):790-800
pubmed: 19361232
Cancers (Basel). 2021 Jul 23;13(15):
pubmed: 34359614
Mol Imaging Biol. 2015 Aug;17(4):575-84
pubmed: 26013479
J Nucl Med. 2019 Jul;60(7):955-962
pubmed: 30683770
Mol Imaging Biol. 2019 Jun;21(3):558-566
pubmed: 30105521
Mol Imaging Biol. 2015 Aug;17(4):565-74
pubmed: 25896814
Dalton Trans. 2019 Nov 14;48(42):15856-15868
pubmed: 31617517
Semin Nucl Med. 2019 Jul;49(4):302-312
pubmed: 31227053
Ann Nucl Med. 2013 Jan;27(1):46-57
pubmed: 23086544
World J Oncol. 2019 Apr;10(2):63-89
pubmed: 31068988
Radiographics. 2018 Jan-Feb;38(1):200-217
pubmed: 29320333
J Nucl Med. 2017 Mar;58(3):425-431
pubmed: 27789722
Nat Rev Urol. 2009 Jun;6(6):317-23
pubmed: 19434102
J Labelled Comp Radiopharm. 2018 Jun 30;61(8):599-605
pubmed: 29575176
Bioconjug Chem. 2012 Apr 18;23(4):688-97
pubmed: 22369515
Clin Adv Hematol Oncol. 2019 Aug;17(8):455-463
pubmed: 31449514
Mol Imaging Biol. 2015 Dec;17(6):777-85
pubmed: 25869080
Pharmaceuticals (Basel). 2021 Jul 23;14(8):
pubmed: 34451810
J Nucl Med. 2017 Oct;58(10):1545-1552
pubmed: 28687599
Asian Pac J Cancer Prev. 2018 Apr 27;19(4):1041-1046
pubmed: 29699054
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):960-968
pubmed: 28280856
Theranostics. 2020 Jan 1;10(1):1-16
pubmed: 31903102
Nat Rev Urol. 2016 Apr;13(4):226-35
pubmed: 26902337
Nat Rev Drug Discov. 2022 May;21(5):327
pubmed: 35396355
Prostate Cancer Prostatic Dis. 2022 Mar;25(1):11-26
pubmed: 34050265
Mol Imaging Biol. 2021 Oct;23(5):745-755
pubmed: 33891265
J Nucl Med. 2019 Jun;60(6):817-823
pubmed: 30389823
Bioconjug Chem. 2011 Aug 17;22(8):1700-5
pubmed: 21740058
J Nucl Med. 2017 Jul;58(7):1081-1087
pubmed: 28209912
Histopathology. 2007 Mar;50(4):472-83
pubmed: 17448023
J Med Chem. 2016 Jun 23;59(12):5684-94
pubmed: 27228467
Am J Nucl Med Mol Imaging. 2018 Aug 20;8(4):247-267
pubmed: 30245917
J Nucl Med. 2019 Mar;60(3):362-368
pubmed: 30042163
Eur Urol. 2016 Dec;70(6):926-937
pubmed: 27363387
Curr Med Chem. 2012;19(6):856-70
pubmed: 22214450
Eur Urol. 2019 Jun;75(6):920-926
pubmed: 30473431
Clin Cancer Res. 2011 Dec 15;17(24):7645-53
pubmed: 22042970
J Med Chem. 2008 Dec 25;51(24):7933-43
pubmed: 19053825
Bioconjug Chem. 2003 Nov-Dec;14(6):1067-76
pubmed: 14624619
J Labelled Comp Radiopharm. 2017 Mar;60(3):168-175
pubmed: 27990672
Mol Imaging Biol. 2017 Dec;19(6):923-932
pubmed: 28639122
Front Oncol. 2018 Dec 20;8:623
pubmed: 30619757
J Nucl Med. 2017 Jun;58(6):947-952
pubmed: 27908968
Mol Imaging Biol. 2016 Jun;18(3):411-9
pubmed: 27080322
Cancer Res. 2009 Sep 1;69(17):6932-40
pubmed: 19706750
Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):486-95
pubmed: 23179945
Cancer Biother Radiopharm. 2020 May;35(4):284-291
pubmed: 32074455
Mol Diagn Ther. 2021 Sep;25(5):647-656
pubmed: 34292532
Diagnostics (Basel). 2021 Mar 19;11(3):
pubmed: 33808825